ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TKNO vs MYGN // FREE CASH FLOW YIELD

Alpha Teknova Inc. (NASDAQ) VS. Myriad Genetics Inc. (NASDAQ) • 15-METRIC TALLY: TKNO 5 — MYGN 5
▲ FREE CASH FLOW YIELD LEADER: MYGN
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TKNO VS. MYGN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TKNO MYGN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 33.20% 69.90% -36.70 MYGN /gross-margins <GO>
Return on Invested Capital (ROIC) -21.30% -35.00% +13.70 TKNO /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -1.96% 0.28% -2.24 MYGN /fcf-yield <GO>
Operating Margin -41.90% -47.00% +5.10 TKNO /operating-margins <GO>
Net Profit Margin -42.60% -44.40% +1.80 TKNO /net-margins <GO>
Revenue Growth (YoY) 7.40% -1.60% +9.00 TKNO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 6.93 0.20 +6.73 TKNO /balance-sheet <GO>
Piotroski F-Score Quality 5/9 6/9 -1.00 MYGN /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 48.1 72.7 -24.55 MYGN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $499.2M $638.0M -$138.8M MYGN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TKNO REV MYGN REV TKNO GROSS % MYGN GROSS % TKNO FCF MYGN FCF
FY 2025 $40.5M $824.5M 33.2% 69.9% -$9.8M $1.8M
FY 2024 $37.7M $837.6M 19.2% 69.9% -$13.5M -$8.7M
FY 2023 $36.7M $753.2M — — -$18.8M -$110.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TKNO // BETA —
MYGN // BETA —